Feature Stories

Africa has the highest global mortality rate among critically ill COVID-19 patients despite having the world’s lowest COVID-19 infections and deaths overall, a recent study published by the Lancet found. Shortage of critical care resources and their underuse are some of the contributing factors. Dr Christian Owoo, a Senior Lecturer in the Department of Anaesthesia, University of Ghana Medical School and a Consultant Anaesthetist/Intensivist and Head of Intensive Care Unit at Korle Bu Teaching Hospital in Accra, discusses ways to prevent severe COVID-19 illness and avert a surge in deaths.

The aircraft engines power down as disembarking passengers rummage through their carry-on bags for documents in readiness for immigration. This is Kigali International Airport, a busy regional hub. The country has implemented an innovative electronic tracking system to stop the domestic spread of COVID-19 from arriving passengers.

More than 480 million people in the African region suffer from oral diseases such as dental caries and periodontal diseases, yet oral health remains a low priority in many countries, leading to inadequate financial and technical investment that undermine prevention and care services.

As the second wave of COVID-19 infections surged in early 2021, Senegal stepped up measures to cope with the anticipated rise in the number of patients needing critical care. Professor Daye Ka, Infectious and Tropical Disease Expert and member of Senegal’s COVID-19 task force, explains the steps taken to avert hospitals being overrun by a drastic rise in critically ill patients.

In the small village of Sinkolé in the densely-forested south-east of Guinea, scores of men and women gather outside a ramshackle community hall on a Friday morning. Marius Djo, a World Health Organization (WHO) advisor on Prevention of Sexual Abuse and Exploitation (PSEA), waits for everyone to take a seat on old wooden school benches arranged in a rough semi-circle, then he begins an animated introduction.

Financial planning is crucial for Africa’s COVID-19 vaccine rollout. Millions of vaccine deliveries are planned for later this year and African countries must urgently plan ahead to quickly roll them out and avoid unplanned costs. The World Bank estimates that each month of delay in the provision of COVID-19 vaccines could cost Africa US$ 14 billion in lost GDP. 

With COVID-19 vaccine supplies to Africa slowing down, the continent is working to boost its own manufacturing capacities for vaccines, medicines and vital health technologies.

Africa’s largest-ever vaccination drive is well under way. Forty-nine African countries are rolling out COVID-19 vaccines and over 22 million doses have been given on the continent. Valuable lessons are emerging, but major risks and challenges threaten Africa’s fragile gains.

The emergence of COVID-19 and the pandemic have raised many challenges regarding treatment and spawned the use of unproven therapies. Professor Lucille Blumberg, the Deputy Director of the South African National Institute for Communicable Diseases, discusses the causes, the risks and how to tackle unproven COVID-19 cures.

On a sultry morning in early March in the small town of Gouécké in south-eastern Guinea, scores of concerned community and customary leaders gathered for a meeting with WHO’s local team of social anthropologists.